Download PDF
CC BY-NC-ND 4.0 · Journal of Fetal Medicine
DOI: 10.1055/s-0044-1788925
Case Report

Fetal Ganglioneuroblastoma: A Rare Entity with Antenatal Diagnosis and Postnatal Follow Up

Alok Varshney 
1   Department of Radiology, Central Diagnostics, New Delhi, India
,
Aakriti Kapoor
2   Department of Radiology, City Xray and Scan Clinic Pvt. Ltd., New Delhi, India
,
Shina Kaur
2   Department of Radiology, City Xray and Scan Clinic Pvt. Ltd., New Delhi, India
,
Tushar Kapoor
2   Department of Radiology, City Xray and Scan Clinic Pvt. Ltd., New Delhi, India
,
Aakaar Kapoor
2   Department of Radiology, City Xray and Scan Clinic Pvt. Ltd., New Delhi, India
,
Apurva Kapoor
2   Department of Radiology, City Xray and Scan Clinic Pvt. Ltd., New Delhi, India
,
Ravi Kapoor
2   Department of Radiology, City Xray and Scan Clinic Pvt. Ltd., New Delhi, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Fetal abdominal masses can be challenging to counsel due to uncertain diagnosis and outcomes. We report a case of a midline upper retroperitoneal mass found incidentally during a routine third trimester ultrasound. Despite not being a suprarenal mass, ultrasound and magnetic resonance imaging indicated neuroblastoma prenatally. With the generally favorable prognosis for prenatally diagnosed neuroblastomas, expectant counseling was given. Postnatal imaging and biopsy confirmed ganglioneuroblastoma, a rare subtype. A conservative approach was taken, and after initial growth, the mass spontaneously regressed 5 months after birth, nearly resolving by 8 months.

Keywords

antenatal - fetal - ganglioneuroblastoma - neuroblastoma - tumor


Publication History

Article published online:
16 August 2024

© 2024. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Cass DL. Fetal abdominal tumors and cysts. Transl Pediatr 2021; 10 (05) 1530-1541
    CrossrefPubMedGoogle Scholar
  • 2 Choi JH, Ro JY. Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: pathology review and diagnostic approach. Semin Diagn Pathol 2022; 39 (02) 120-130
    CrossrefPubMedGoogle Scholar
  • 3 Körber V, Stainczyk SA, Kurilov R. et al. Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome. Nat Genet 2023; 55 (04) 619-630
    CrossrefPubMedGoogle Scholar
  • 4 Van Arendonk KJ, Chung DH. Neuroblastoma: tumor biology and its implications for staging and treatment. Children (Basel) 2019; 6 (01) 12
    PubMedGoogle Scholar
  • 5 Maki E, Oh K, Rogers S, Sohaey R. Imaging and differential diagnosis of suprarenal masses in the fetus. J Ultrasound Med 2014; 33 (05) 895-904
    CrossrefPubMedGoogle Scholar
  • 6 Andrei C, Vladareanu R, Zvanca M, Vladareanu S. Prenatal diagnosis of neuroblastoma. Donald Sch J Ultrasound Obstet Gynecol 2014; 8: 321-327
    CrossrefGoogle Scholar
  • 7 Werner H, Daltro P, Davaus T, Araujo Júnior E. Fetal neuroblastoma: ultrasonography and magnetic resonance imaging findings in the prenatal and postnatal IV-S stage. Obstet Gynecol Sci 2016; 59 (05) 407-410
    CrossrefPubMedGoogle Scholar
  • 8 Shin SI, Yoo JG, Park IY, Cheon JY. Prenatal diagnosis of fetal adrenal hemorrhage and endocrinologic evaluation. Obstet Gynecol Sci 2016; 59 (03) 238-240
    CrossrefPubMedGoogle Scholar
  • 9 Varlas V, Neagu O, Moga A. et al. Fetal pancreatic hamartoma associated with hepatoblastoma-an unusual tumor association. Diagnostics (Basel) 2022; 12 (03) 758
    CrossrefPubMedGoogle Scholar
  • 10 Brodeur GM. Spontaneous regression of neuroblastoma. Cell Tissue Res 2018; 372 (02) 277-286
    CrossrefPubMedGoogle Scholar